title: Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma.
abstract: Cutaneous stereoselective hydrolyses of ten ester prodrugs of propranolol in hairless mouse were compared to those in liver and plasma. On the basis of protein content, the hydrolysis rate was greatest with liver homogenate followed by plasma and skin homogenate. The buffer showed the slowest and non-stereoselective hydrolysis. However, skin showed very high stereoselectivity (R/S ratio: 6.7-18.4) as compared with liver (0.7-2.0) and plasma (1.7-4.7). The microsomal esterase activity was higher than cytosolic esterase in liver, while an opposite relation was observed in skin. The smaller Km and larger Vmax values of the (R) isomer than those of the (S) isomer of caproyl- and/or butyryl-propranolol were found in skin and plasma, while Km was the same between (R) and (S) isomers in liver. Enzyme inhibition studies indicated that the carboxylesterases were primarily involved in prodrug hydrolysis in liver. On the other hand, skin and plasma were found to be rich in both carboxylesterases and cholinesterases. Interestingly, the (R) isomer was more sensitive towards butylcholinesterase in skin and plasma, while (S) isomer was more sensitive towards carboxylesterase in plasma. Moreover, no stereoselective inhibition was observed in liver. These data indicated that the hydrolyzing nature of skin esterases responsible for propranolol prodrug was sensitive against stereochemical configuration and more similar to those in plasma esterases than liver esterases.
authors.affiliation: Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Ahmed
authors.forename: T
authors.initials: T
authors.lastname: Imai
authors.forename: Y
authors.initials: Y
authors.lastname: Yoshigae
authors.forename: M
authors.initials: M
authors.lastname: Otagiri
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000493:pharmacokinetics*; D000818:Animals; D003600:Cytosol / Q000201:enzymology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004950:Esterases / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism*; D006868:Hydrolysis; D007700:Kinetics; D008099:Liver / Q000201:enzymology*; D051379:Mice; D008812:Mice, Hairless; D008861:Microsomes / Q000201:enzymology; D011355:Prodrugs / Q000493:pharmacokinetics*; D011433:Propranolol / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D012867:Skin / Q000201:enzymology*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013347:Subcellular Fractions / Q000201:enzymology
chemical_list: D000319:Adrenergic beta-Antagonists; D004791:Enzyme Inhibitors; D011355:Prodrugs; D011433:Propranolol; D004950:Esterases